Category Archives: Emerging Markets

New Global Alliance for Improvement of HIV Diagnostics

The Joint United Nations Programme on HIV/AIDS (UNAIDS) and the African Society for Laboratory Medicine (ASLM) have joined with a number of global partners to launch the Diagnostics Access Initiative. Partners in the Initiative, which calls for improving laboratory capacity so that all people living with HIV can be linked to effective HIV treatment services, include […]
Also posted in Global, healthcare | Tagged , , , , , , , , , | Leave a comment

Is There Potential for Growth in Brazil’s Phytotherapic Drug Market?

It is well known that Brazil has an immense biodiversity and that the Amazon is the largest tropical rainforest in the world. Traditional Brazilian medicines include African elements, rooted on indigenous groups. Few pharmaceutical companies, however, know at what level phytotherapic drugs are commercialized in the country, how much regulation is imposed for herbal medicines, […]
Also posted in Global, Guest Blog | Tagged , , , , | Leave a comment

BIO 2014 Takeaway: The Peace Dividend

A surprising take away from the BIO International Convention in San Diego last month is the stark contrast between cooperative industry engagement and an unstable geopolitical order marked by xenophobia, drift and active, often violent government disengagement from the hard work of building common ground. While BIO held 29,000 partnering meetings over four days, convened […]
Also posted in Biotech, Europe, Events, Global | Tagged , , | Leave a comment

The Decline of Clinical Trials in Central and Eastern Europe

Currently, 66% of clinical trials are conducted in North America, Western Europe and Australia.  The U.S. hosts 49% of clinical trial sites and generates approximately 40% of clinical data.  Other regions have arisen in recent years.  The main reasons behind this globalization trend are the availability of highly skilled professionals in new research markets, lower […]
Also posted in Europe, Global, R&D | Tagged , , , , , | Leave a comment

US Regulators and Industry Bodies Push Forward with Global Expansion

At the annual meeting of the Food and Drug Law Institute (FDLI) this year, FDA commissioner Margaret Hamburg concluded her keynote address by describing a “dramatically changing global marketplace” and its “huge implications” for FDA’s ability to ensure the safety and quality of products manufactured elsewhere. In addition to conducting more inspections and oversight of […]
Also posted in Europe, FDA, Global, Regulatory | Tagged , , , , , , | Leave a comment
  • Categories

  • Meta